共 14 条
- [1] Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis (vol 15, pg 293, 2015) LANCET INFECTIOUS DISEASES, 2015, 15 (03): : 263 - 263
- [2] Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis LANCET INFECTIOUS DISEASES, 2015, 15 (03): : 293 - 300
- [3] Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (09): : 1511 - 1520
- [4] Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years (vol 220, pg 1511, 2019) JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (01): : 168 - 168
- [6] Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014 JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (04): : 510 - 517
- [8] Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1459 - 1466
- [10] Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial LANCET RESPIRATORY MEDICINE, 2017, 5 (09): : 738 - 746